Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

8.95
Delayed Data
As of Sep 24
 -0.105 / -1.16%
Today’s Change
8.24
Today|||52-Week Range
13.30
-7.31%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$9.9B

Company Description

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The firm operates through following geographical segments: North America, Europe and International Markets. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

Contact Information

Teva Pharmaceutical Industries Ltd.
5 Basel Street
Petach Tikva Hamerkaz 4951033
P:(723) 926-7267
Investor Relations:
(215) 591-8912

Employees

Shareholders

Other institutional28.80%
Mutual fund holders22.60%
Individual stakeholders0.14%

Top Executives

Kåre SchultzPresident, Chief Executive Officer & Director
Eric DrapéExecutive Vice President-Global Operations
Eli KalifChief Financial Officer & Executive Vice President
Hafrun FridriksdottirExecutive VP-Global Research & Development
Lori A. QueisserSenior Vice President & Global Compliance Officer